Home › Depression › Florida › Deltona
Depression clinical trials in Deltona, FL
4 studies for Depression are looking for participants at sites in and around Deltona (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- Medical Research Group of Central Florida, Orange City · 4 mi away
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RecruitingPhase 3
- Optimal Research Sites, Orange City · 4 mi away
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Halifax Health Cancer Center for Hope - Daytona Beach, Daytona Beach · 26 mi away
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RecruitingPhase 3
- Medical Research Group of Central Florida /ID# 256757, Orange City · 4 mi away
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA51 studies
- New York City, NY46 studies
- Philadelphia, PA25 studies
- Chicago, IL23 studies
- Atlanta, GA23 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Deltona
- Non-Small Cell Lung Cancer15 studies
- Obesity11 studies
- Alzheimer's Disease10 studies
- Overweight9 studies
- Type 2 Diabetes9 studies
- Lung Cancer8 studies
- Breast Cancer8 studies
- Cancer (all types)7 studies
- Melanoma5 studies
- High Blood Pressure5 studies
- Knee Osteoarthritis5 studies
- Metastatic Cancer5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.